Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00004184 · COMPLETED

Trial details

NCT number: NCT00004184
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1998-08-01
Primary completion: 2001-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.